Opposing effects of RAS on p53: Transcriptional activation of mdm2 and induction of p19(ARF)

Stefan Ries, Carola Biederer, Douglas Woods, Ohad Shifman, Senji Shirasawa, Takehiko Sasazuki, Martin McMahon, Moshe Oren, Frank McCormick

Research output: Contribution to journalArticle

310 Citations (Scopus)

Abstract

Mdm2 acts as a major regulator of the tumor suppressor p53 by targeting its destruction. Here, we show that the mdm2 gene is also regulated by the Ras-driven Raf/MEK/MAP kinase pathway, in a p53-independent manner. Mdm2 induced by activated Raf degrades p53 in the absence of the Mdm2 inhibitor p19(ARF). This regulatory pathway accounts for the observation that cells transformed by oncogenic Ras are more resistant to p53-dependent apoptosis following exposure to DNA damage. Activation of the Ras-induced Raf/MEK/MAP kinase may therefore play a key role in suppressing p53 during tumor development and treatment. In primary cells, Raf also activates the Mdm2 inhibitor p19(ARF). Levels of p53 are therefore determined by opposing effects of Raf-induced p19(ARF) and Mdm2.

Original languageEnglish
Pages (from-to)321-330
Number of pages10
JournalCell
Volume103
Issue number2
DOIs
Publication statusPublished - Oct 13 2000

Fingerprint

MAP Kinase Kinase Kinases
Mitogen-Activated Protein Kinase Kinases
Transcriptional Activation
Tumors
Phosphotransferases
Chemical activation
DNA Damage
Neoplasms
Genes
Apoptosis
DNA

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Ries, S., Biederer, C., Woods, D., Shifman, O., Shirasawa, S., Sasazuki, T., ... McCormick, F. (2000). Opposing effects of RAS on p53: Transcriptional activation of mdm2 and induction of p19(ARF). Cell, 103(2), 321-330. https://doi.org/10.1016/S0092-8674(00)00123-9

Opposing effects of RAS on p53 : Transcriptional activation of mdm2 and induction of p19(ARF). / Ries, Stefan; Biederer, Carola; Woods, Douglas; Shifman, Ohad; Shirasawa, Senji; Sasazuki, Takehiko; McMahon, Martin; Oren, Moshe; McCormick, Frank.

In: Cell, Vol. 103, No. 2, 13.10.2000, p. 321-330.

Research output: Contribution to journalArticle

Ries, S, Biederer, C, Woods, D, Shifman, O, Shirasawa, S, Sasazuki, T, McMahon, M, Oren, M & McCormick, F 2000, 'Opposing effects of RAS on p53: Transcriptional activation of mdm2 and induction of p19(ARF)', Cell, vol. 103, no. 2, pp. 321-330. https://doi.org/10.1016/S0092-8674(00)00123-9
Ries S, Biederer C, Woods D, Shifman O, Shirasawa S, Sasazuki T et al. Opposing effects of RAS on p53: Transcriptional activation of mdm2 and induction of p19(ARF). Cell. 2000 Oct 13;103(2):321-330. https://doi.org/10.1016/S0092-8674(00)00123-9
Ries, Stefan ; Biederer, Carola ; Woods, Douglas ; Shifman, Ohad ; Shirasawa, Senji ; Sasazuki, Takehiko ; McMahon, Martin ; Oren, Moshe ; McCormick, Frank. / Opposing effects of RAS on p53 : Transcriptional activation of mdm2 and induction of p19(ARF). In: Cell. 2000 ; Vol. 103, No. 2. pp. 321-330.
@article{580c3e96da944885835071692c00407b,
title = "Opposing effects of RAS on p53: Transcriptional activation of mdm2 and induction of p19(ARF)",
abstract = "Mdm2 acts as a major regulator of the tumor suppressor p53 by targeting its destruction. Here, we show that the mdm2 gene is also regulated by the Ras-driven Raf/MEK/MAP kinase pathway, in a p53-independent manner. Mdm2 induced by activated Raf degrades p53 in the absence of the Mdm2 inhibitor p19(ARF). This regulatory pathway accounts for the observation that cells transformed by oncogenic Ras are more resistant to p53-dependent apoptosis following exposure to DNA damage. Activation of the Ras-induced Raf/MEK/MAP kinase may therefore play a key role in suppressing p53 during tumor development and treatment. In primary cells, Raf also activates the Mdm2 inhibitor p19(ARF). Levels of p53 are therefore determined by opposing effects of Raf-induced p19(ARF) and Mdm2.",
author = "Stefan Ries and Carola Biederer and Douglas Woods and Ohad Shifman and Senji Shirasawa and Takehiko Sasazuki and Martin McMahon and Moshe Oren and Frank McCormick",
year = "2000",
month = "10",
day = "13",
doi = "10.1016/S0092-8674(00)00123-9",
language = "English",
volume = "103",
pages = "321--330",
journal = "Cell",
issn = "0092-8674",
publisher = "Cell Press",
number = "2",

}

TY - JOUR

T1 - Opposing effects of RAS on p53

T2 - Transcriptional activation of mdm2 and induction of p19(ARF)

AU - Ries, Stefan

AU - Biederer, Carola

AU - Woods, Douglas

AU - Shifman, Ohad

AU - Shirasawa, Senji

AU - Sasazuki, Takehiko

AU - McMahon, Martin

AU - Oren, Moshe

AU - McCormick, Frank

PY - 2000/10/13

Y1 - 2000/10/13

N2 - Mdm2 acts as a major regulator of the tumor suppressor p53 by targeting its destruction. Here, we show that the mdm2 gene is also regulated by the Ras-driven Raf/MEK/MAP kinase pathway, in a p53-independent manner. Mdm2 induced by activated Raf degrades p53 in the absence of the Mdm2 inhibitor p19(ARF). This regulatory pathway accounts for the observation that cells transformed by oncogenic Ras are more resistant to p53-dependent apoptosis following exposure to DNA damage. Activation of the Ras-induced Raf/MEK/MAP kinase may therefore play a key role in suppressing p53 during tumor development and treatment. In primary cells, Raf also activates the Mdm2 inhibitor p19(ARF). Levels of p53 are therefore determined by opposing effects of Raf-induced p19(ARF) and Mdm2.

AB - Mdm2 acts as a major regulator of the tumor suppressor p53 by targeting its destruction. Here, we show that the mdm2 gene is also regulated by the Ras-driven Raf/MEK/MAP kinase pathway, in a p53-independent manner. Mdm2 induced by activated Raf degrades p53 in the absence of the Mdm2 inhibitor p19(ARF). This regulatory pathway accounts for the observation that cells transformed by oncogenic Ras are more resistant to p53-dependent apoptosis following exposure to DNA damage. Activation of the Ras-induced Raf/MEK/MAP kinase may therefore play a key role in suppressing p53 during tumor development and treatment. In primary cells, Raf also activates the Mdm2 inhibitor p19(ARF). Levels of p53 are therefore determined by opposing effects of Raf-induced p19(ARF) and Mdm2.

UR - http://www.scopus.com/inward/record.url?scp=0034644506&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034644506&partnerID=8YFLogxK

U2 - 10.1016/S0092-8674(00)00123-9

DO - 10.1016/S0092-8674(00)00123-9

M3 - Article

C2 - 11057904

AN - SCOPUS:0034644506

VL - 103

SP - 321

EP - 330

JO - Cell

JF - Cell

SN - 0092-8674

IS - 2

ER -